NeogenFRA:NG2 -4.30%68 OCF Margin % is 10.75% as of Feb. 2026, which is 24% below its 10-year median of 14.16. GuruFocus rates FRA:NG2 with a GF Score™ of 68/100 and a GF Value™ of €10.66 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Neogen ranks better than 53.74% on this metric.
The historical rank and industry rank for Neogen's OCF Margin % or its related term are showing as below:
FRA:NG2'
s OCF Margin % Range Over the Past 10 Years
Min: 3.82 Med: 14.16 Max: 20.54
Current: 7.96
During the past 13 years, the highest OCF Margin % of Neogen was 20.54%. The lowest was 3.82%. And the median was 14.16%.
FRA:NG2's OCF Margin % is ranked better than 53.74% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs FRA:NG2: 7.96
Neogen OCF Margin % Related Terms
Neogen OCF Margin % Historical Data
* Premium members only.
The historical data trend for Neogen's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:NG2 vs NVCR, ESTA, AXGN: OCF Margin % Comparison
For the Medical Devices subindustry, Neogen's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neogen OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Neogen's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Neogen's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neogen (FRA:NG2) has a OCF Margin % of 10.75% as of Feb. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Neogen and its competitors. This is 24% below median its historical median of 14.16. Over the past decade, Neogen's OCF Margin % has ranged from 3.82 to 20.54. According to the industry distribution chart, Neogen ranks #377 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 46.3%.
Is Neogen's OCF Margin % too high?
Neogen's current OCF Margin % of 10.75% is 24% below median its 10-year median of 14.16. Over the past 10 years, this metric has ranged from a low of 3.82 to a high of 20.54. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Neogen's value of 10.75% is 83.4% above this industry median. Based on the distribution chart, Neogen ranks #377 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Neogen has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neogen's OCF Margin % compare to NVCR and ESTA?
According to the Medical Devices & Instruments industry distribution chart, Neogen ranks #377 out of 815 companies for OCF Margin %. This puts Neogen in the upper half of its industry. The industry median OCF Margin % is 5.86. Neogen's value of 10.75% is 83.4% above this benchmark. Historically, Neogen's own OCF Margin % has ranged from 3.82 to 20.54 over the past decade. While the company's 10-year median is 14.16 vs. the industry median of 5.86, Neogen has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neogen's current OCF Margin % of 10.75% is 83.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Neogen and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neogen's current OCF Margin % is 10.75%, which is 24% below median its own 10-year median of 14.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neogen stock overvalued right now?
Based on GuruFocus' analysis, Neogen (FRA:NG2) is currently considered Modestly Undervalued. The stock's GF Value™ is €10.66, compared to a current price of €7.65 — trading 28.2% below its estimated fair value. The current OCF Margin % is 10.75%, which is 24% below median its 10-year median of 14.16 and 83.4% above the Medical Devices & Instruments industry median of 5.86. Neogen's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Neogen (FRA:NG2), the current OCF Margin % is 10.75% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neogen (FRA:NG2) Overvalued in 2026?
Based on GuruFocus' analysis, Neogen stock appears to be undervalued.
The current stock price of €7.65 is trading 28.2% below its estimated GF Value™ of €10.66.
GuruFocus considers Neogen to be Modestly Undervalued.
Key valuation signals for FRA:NG2:
OCF Margin %: 10.75% (24% below median its 10-year median of 14.16)
GF Value™: €10.66 vs. price of €7.65 (28.2% below fair value)
Industry Position: 83.4% above the Medical Devices & Instruments median (#377 of 815)
No single metric tells the full story. See the FRA:NG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
68GF Score
Get the complete analysis for FRA:NG2
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NG2 has been successfully added to your 
